INTERNATIONAL PATENT: MORPHOSYS AG FILES APPLICATION FOR "DUAL-TARGETING OF MUC16 AND MESOTHELIN CO-EXPRESSING TUMOR CELLS BY FUNCTIONAL COMPLEMENTATION OF CYCAT(R) HALFBODY MOLECULES"

GENEVA, April 28 -- MORPHOSYS AG (Semmelweisstr. 782152 Planegg) filed a patent application (PCT/EP2024/078140) for "DUAL-TARGETING OF MUC16 AND MESOTHELIN CO-EXPRESSING TUMOR CELLS BY FUNCTIONAL COMPLEMENTATION OF CYCAT(R) HALFBODY MOLECULES" on Oct 07, 2024. With publication no. WO/2025/082777, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ERKEL, Christoph (Huegelstrasse 1482178 Puchheim), STEIN, Felicitas (Am Wagnerberg 1285653 Aying), SCHUSTER, Simon (RheinstraBe 1179241 Ihringen), DICKOPF, Steffen (Ludwig-Marz-Str....